GlassScriptPhysician profile
Cornel Rogers
NPI 1750605770
$12,811.28
in general payments reported to CMS, 2019-2025
40 companies · $3,059 in 2025
The $3,059 reported for 2025 was more than what 80% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $687 · 2021: $1,924 · 2022: $2,390 · 2023: $1,795 · 2024: $2,381 · 2025: $3,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,354 · Travel and Lodging: $843 · Education: $38.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,353.80 |
| Travel and Lodging | $842.87 |
| Education | $38.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,998.65 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Eisai INC. | $1,543.25 | 2019-2025 | |
| Ucb, INC. | $1,453.85 | 2019-2025 | Briviact, Fintepla, Rystiggo |
| Livanova USA, INC. | $1,143.32 | 2025 | Vns Therapy |
| Jazz Pharmaceuticals INC. | $1,010.88 | 2022-2025 | Epidiolex |
| Emd Serono, INC. | $682.59 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $645.90 | 2019-2024 | Qelbree |
| Neurelis, INC. | $460.32 | 2020-2025 | Valtoco |
| Lundbeck LLC | $249.87 | 2023-2025 | Rexulti, Vyepti |
| Kyowa Kirin, INC. | $243.30 | 2021-2024 | Nourianz |
| Sk Life Science, INC. | $218.78 | 2020-2023 | |
| Argenx US, INC. | $205.99 | 2022-2024 | Vyvgart Hytrulo, Vyvgart |
| Biogen, INC. | $184.75 | 2021-2025 | Tysabri, Vumerity, Skyclarys |
| Amgen INC. | $152.89 | 2020-2025 | Uplizna |
| Celgene Corporation | $152.43 | 2021-2023 | Zeposia |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cornel Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.